Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2015 Apr 20;24(6):1276–1281. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.037

Table 3. Outcomes of Study Groups.

Group 1 Group 2 Group 3 Group 4
Mild Definition NIHSS 0-5 TREAT NIHSS 0-5 TREAT
Baseline mRS 0 0 0-5 0-5
Number of Patients 276 184 374 251
 treated 83 (30%) 45 (24.5%) 105 (28.1%) 58 (23.1%)
 untreated 193 (70%) 139 (75.5%) 269 (71.9%) 193 (76.9%)
 TMT (too mild to treat) 113 87 155 123
 TMT-only 40 33 57 46
Poor outcome at 90 days
 treated vs untreated 37.4% vs 31.1%, adjusted p=0.44 35.6% vs 28.8%, adjusted p=0.47 38.1% vs 32.3%, adjusted p=0.67 32.8% vs 29.0%, adjusted p=0.47
 TMT vs rest of untreated 29.2% vs 33.8%, adjusted p=0.48 25.3% vs 34.6%, adjusted p=0.95 29.7% vs 36.0%, adjusted p=0.95 26.0% vs 34.3%,adjusted p=0.59
 TMT-only vs treated 25% vs 37.35%, adjusted p=0.67 15.2% vs 35.6%, adjusted p=0.28 29.8% vs 38.1%, adjusted p=0.72 21.7% vs 32.8%, adjusted p=0.96
Symptomatic ICH (among treated) 0 0 3 (2.9%) 2 (4.0%)